ID: ALA3945133

Max Phase: Preclinical

Molecular Formula: C38H51N3O9S

Molecular Weight: 725.91

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCC[C@]1(CC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)N[C@@H]3O[C@H](CO)[C@@H](O)[C@H](OCc4ccccc4)[C@H]3O)c2)[C@H]1O

Standard InChI:  InChI=1S/C38H51N3O9S/c1-5-7-18-38(6-2)23-51(47,48)30-17-16-27(41(3)4)20-28(30)31(35(38)45)25-14-11-15-26(19-25)39-37(46)40-36-33(44)34(32(43)29(21-42)50-36)49-22-24-12-9-8-10-13-24/h8-17,19-20,29,31-36,42-45H,5-7,18,21-23H2,1-4H3,(H2,39,40,46)/t29-,31-,32-,33-,34+,35-,36-,38-/m1/s1

Standard InChI Key:  NLPRUKQLVITDKM-RTNCXNSASA-N

Associated Targets(Human)

Ileal bile acid transporter 415 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 725.91Molecular Weight (Monoisotopic): 725.3346AlogP: 3.77#Rotatable Bonds: 12
Polar Surface Area: 177.89Molecular Species: NEUTRALHBA: 10HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.48CX Basic pKa: 2.23CX LogP: 3.87CX LogD: 3.87
Aromatic Rings: 3Heavy Atoms: 51QED Weighted: 0.16Np Likeness Score: 0.12

References

1.  (2010)  Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof, 

Source